Discovering transthyretin amyloid fibril inhibitors by limited screening
- 1 August 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 6 (8) , 1389-1401
- https://doi.org/10.1016/s0968-0896(98)00130-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesisNature, 1997
- For Protein Misassembly, It's the “I” DecadeCell, 1996
- Alternative conformations of amyloidogenic proteins govern their behaviorCurrent Opinion in Structural Biology, 1996
- The Acid-Mediated Denaturation Pathway of Transthyretin Yields a Conformational Intermediate That Can Self-Assemble into AmyloidBiochemistry, 1996
- Comparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid DiseaseBiochemistry, 1995
- A role for destabilizing amino acid replacements in light-chain amyloidosis.Proceedings of the National Academy of Sciences, 1994
- Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicityBiochemistry, 1993
- Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitroBiochemistry, 1992
- Genetic Aspects of AmyloidosisPublished by Springer Nature ,1991
- Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbuminBiochemical and Biophysical Research Communications, 1988